Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (177)	5/16/2000 1:34:00 PM
From: tuck	Read Replies (1) \| Respond to of 1833

Rick, Also instructive to compare this Q to the prior Q to complete the lesson in how a company transforms itself into a shell ('tis easier to provide link than try to format the durn thing here): siliconinvestor.com For example, last Q there were R&D expenses; this Q there aren't. I remember that this is how CLPA got started: through the Tseng Labs shell. Whatever you think of CLPA as a company, the stock has certainly treated those shareholders who bought in at the Tseng shell stage very well indeed. Hence my continued interest in this company. I'm very tempted to nibble a thousand shares today. Cheers, Tuck